Hefei Lifeon Pharmaceutical Co., Ltd. (SZSE:003020) signed equity transfer agreement to acquire 51% stake in Anhui Joyfar Pharmaceutical Co. Ltd. from Beijing Huixu Jintong Investment Center (Limited Partnership), Beijing Huixu Jintai Investment Center (Limited Partnership), Gong Tonglin, Shen Jun, Zhao Shoutian and Ouyang Hanlin for approximately CNY 220 million on August 25, 2023. The transaction is approved by board of directors of Hefei Lifeon Pharmaceutical Co., Ltd. As of March 31, 2023, Anhui Joyfar Pharmaceutical Co.

Ltd. generated total assets of CNY 331.2 million and net assets of CNY 247.7 million.